CANO HEALTH INC (CANO)
US13781Y2028 - Common Stock
Overall CANO gets a fundamental rating of 1 out of 10. We evaluated CANO against 109 industry peers in the Health Care Providers & Services industry. CANO may be in some trouble as it scores bad on both profitability and health. CANO is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
CANO had negative earnings in the past year.
CANO had a negative operating cash flow in the past year.
1.2 Ratios
With a Return On Assets value of -47.69%, CANO is not doing good in the industry: 85.22% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -47.69% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-7.72%
ROA(5y)N/A
ROE(3y)-77.02%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CANO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
CANO does not have a ROIC to compare to the WACC, probably because it is not profitable.
CANO has less shares outstanding than it did 1 year ago.
The debt/assets ratio for CANO is higher compared to a year ago.
2.2 Solvency
CANO has an Altman-Z score of 0.33. This is a bad value and indicates that CANO is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CANO (0.33) is worse than 66.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.33 |
ROIC/WACCN/A
WACC5.13%
2.3 Liquidity
CANO has a Current Ratio of 0.40. This is a bad value and indicates that CANO is not financially healthy enough and could expect problems in meeting its short term obligations.
CANO's Current ratio of 0.40 is on the low side compared to the rest of the industry. CANO is outperformed by 91.30% of its industry peers.
A Quick Ratio of 0.40 indicates that CANO may have some problems paying its short term obligations.
CANO's Quick ratio of 0.40 is on the low side compared to the rest of the industry. CANO is outperformed by 91.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.4 | ||
| Quick Ratio | 0.4 |
3. Growth
3.1 Past
The earnings per share for CANO have decreased strongly by -343.95% in the last year.
CANO shows a strong growth in Revenue. In the last year, the Revenue has grown by 25.69%.
CANO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 96.42% yearly.
EPS 1Y (TTM)-343.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-299.43%
Revenue 1Y (TTM)25.69%
Revenue growth 3Y96.42%
Revenue growth 5YN/A
Sales Q2Q%18.51%
3.2 Future
Based on estimates for the next years, CANO will show a very negative growth in Earnings Per Share. The EPS will decrease by -50.04% on average per year.
The Revenue is expected to grow by 2.24% on average over the next years.
EPS Next Y-1383.78%
EPS Next 2Y-122.5%
EPS Next 3Y-50.04%
EPS Next 5YN/A
Revenue Next Year16.84%
Revenue Next 2Y1.95%
Revenue Next 3Y2.61%
Revenue Next 5Y2.24%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CANO. In the last year negative earnings were reported.
Also next year CANO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
CANO's earnings are expected to decrease with -50.04% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-122.5%
EPS Next 3Y-50.04%
5. Dividend
5.1 Amount
No dividends for CANO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CANO HEALTH INC
NYSE:CANO (2/2/2024, 8:04:00 PM)
Premarket: 1.17 -1.13 (-49.13%)2.3
-0.05 (-2.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners9.13%
Inst Owner Change-0.06%
Ins Owners387.39%
Ins Owner Change-1.42%
Market Cap12.44M
Analysts48.89
Price Target4.85 (110.87%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-357.38%
Min EPS beat(2)-389.24%
Max EPS beat(2)-325.53%
EPS beat(4)2
Avg EPS beat(4)-77.16%
Min EPS beat(4)-389.24%
Max EPS beat(4)402.66%
EPS beat(8)5
Avg EPS beat(8)-55.04%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-4.53%
Min Revenue beat(2)-9.27%
Max Revenue beat(2)0.21%
Revenue beat(4)3
Avg Revenue beat(4)-0.46%
Min Revenue beat(4)-9.27%
Max Revenue beat(4)5.3%
Revenue beat(8)4
Avg Revenue beat(8)-4.42%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)295.83%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-15217%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-0.37%
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)0.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-115.87
EYN/A
EPS(NY)-38.06
Fwd EYN/A
FCF(TTM)-32.43
FCFYN/A
OCF(TTM)-27.14
OCFYN/A
SpS573.4
BVpS-22.57
TBVpS-173.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -47.69% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-7.72%
ROA(5y)N/A
ROE(3y)-77.02%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover2.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 26.58% | ||
| Cap/Sales | 0.92% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.4 | ||
| Quick Ratio | 0.4 | ||
| Altman-Z | 0.33 |
F-Score2
WACC5.13%
ROIC/WACCN/A
Cap/Depr(3y)63.12%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.8%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-343.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-299.43%
EPS Next Y-1383.78%
EPS Next 2Y-122.5%
EPS Next 3Y-50.04%
EPS Next 5YN/A
Revenue 1Y (TTM)25.69%
Revenue growth 3Y96.42%
Revenue growth 5YN/A
Sales Q2Q%18.51%
Revenue Next Year16.84%
Revenue Next 2Y1.95%
Revenue Next 3Y2.61%
Revenue Next 5Y2.24%
EBIT growth 1Y-134.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-168.37%
EBIT Next 3Y43.75%
EBIT Next 5Y35.27%
FCF growth 1Y-48.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-54.37%
OCF growth 3YN/A
OCF growth 5YN/A